IDH1 and glioblastoma: However, glioblastoma, by definition, lacks an IDH mutation; therefore, measurement of 2-HG is of no utility, which has shifted the investigation towards other metabolites, such as different concentration ratios of choline/NAA and choline/creatine to differentiate true progression of glioblastoma from pseudoprogression [52].